Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Creative Peptides

Creative peptides is specialized in the process development and the manufacturing of bioactive peptides. We offer custom peptide synthesis, process development, GMP manufacturing as well as catalog products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

Creative Peptides
17 Ramsey Road, Shirley, NY 11967, USA
+1 631 624 4882
Contact Creative Peptides
Website

 Latest Content from PMHub 

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

Press Releases | March 2, 2022 | Lucid Group Communications Limited

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Nucleus Global launches new branding as it sets its sights on the future

Press Releases | March 1, 2022 | Nucleus Global

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

White paper: Are we prepared for the influx of CAR-Ts?

White Papers and Resources | March 1, 2022 | Inizio

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Shining a light on rare diseases with ‘Noah’s Story’

Press Releases | February 28, 2022 | Resonant Group

In recognition of Rare Disease Day, Bedrock share 4 minutes of a true story you won’t want to miss.

Accession welcomes Graham Ridgway as Non-Executive Chairman

Press Releases | February 25, 2022 | Accession

Accession, a specialist pharma market access consulting and software company, announces the appointment of accomplished software CEO Graham Ridgway as Non-Executive Chairman.

Rare Disease Day – looking to the future with hope

Press Releases | February 25, 2022 | Nucleus Global

On this year’s Rare Disease Day, Amanda Henkel, VP, Strategy, Nucleus X Consulting (part of Nucleus Global), reflects on recent advances in the rare disease setting.

Bridging the gender health gap: 9 key takeaways from Thrive’s webinar on tech and women’s health

Press Releases | February 25, 2022 | Thrive Agency

Unequal health outcomes have been a reality for women throughout the world for far too long. But change is finally happening.

Bedrock to raise awareness of Rare Disease Day 2022 with film ‘Noah’s Story’

Press Releases | February 25, 2022 | Resonant Group

Emily Wigginton, Bedrock’s Head of Client Services explains the inspiration behind the film.

Eating Disorders Awareness Week

White Papers and Resources | February 25, 2022 | Innovative Trials

In the latest blog post, Innovative Trials' Equality & Diversity committee focuses on eating disorders

Social Health Prescription: Connecting People, Empowering Patients, & Improving Outcomes

Videos and Podcasts | February 25, 2022 | Impetus Digital

Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. She also explores questions such as how AI and “intelligent matchmaking” can be leveraged...